Cerus Corporation
$2.05
▼
-0.53%
2026-04-21 05:59:00
www.cerus.com
NGM: CERS
Explore Cerus Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$397.8 M
Current Price
$2.05
52W High / Low
$2.96 / $1.15
Stock P/E
—
Book Value
$0.33
Dividend Yield
—
ROCE
-7.17%
ROE
-25.66%
Face Value
—
EPS
$-0.08
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
261
Beta
1.63
Debt / Equity
149.23
Current Ratio
1.73
Quick Ratio
1.17
Forward P/E
-378
Price / Sales
1.76
Enterprise Value
$378.01 M
EV / EBITDA
-52.1
EV / Revenue
1.83
Rating
None
Target Price
$5
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Adagio Medical Holdings, Inc. | $1.53 | — | $34.43 M | — | -62.51% | -1.55% | $2.87 / $0.74 | $0.56 |
| 2. | SANUWAVE Health, Inc. | $19.94 | 14.99 | $177.13 M | — | 25.36% | -166.66% | $46.59 / $16.27 | $0.19 |
| 3. | CapsoVision, Inc. | $6.01 | — | $299.53 M | — | -185.75% | -1.85% | $15.37 / $3.43 | $0.28 |
| 4. | CeriBell, Inc. | $21.13 | — | $797.62 M | — | -33.07% | -30.83% | $24.33 / $10.85 | $4.14 |
| 5. | LENSAR, Inc. | $5.55 | — | $71.73 M | — | -79.65% | -10.69% | $14.31 / $5.33 | $-2.17 |
| 6. | CONMED Corporation | $39.68 | 25.61 | $1.2 B | 2.05% | 5.1% | 4.71% | $61.08 / $33.21 | $33.36 |
| 7. | HeartSciences Inc. | $2.05 | — | $6.85 M | — | -1607.2% | -3.82% | $6.47 / $1.89 | $0.83 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 57.75 M | 52.7 M | 52.45 M | 43.24 M | 50.81 M | — |
| Operating Profit | -0.64 M | 1.24 M | -3.42 M | -5.85 M | -1.45 M | — |
| Net Profit | -2.18 M | -0.02 M | -5.71 M | -7.72 M | -2.52 M | — |
| EPS in Rs | -0.01 | -0 | -0.03 | -0.04 | -0.01 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 206.13 M | 180.27 M | 156.37 M | 162.05 M |
| Operating Profit | -8.68 M | -14.22 M | -26.32 M | -34.08 M |
| Net Profit | -15.63 M | -20.92 M | -37.49 M | -42.78 M |
| EPS in Rs | -0.08 | -0.11 | -0.2 | -0.22 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 221.86 M | 200.92 M | 197.75 M | 218.09 M |
| Total Liabilities | 156.89 M | 144.02 M | 144.3 M | 149.53 M |
| Equity | 64.22 M | 56.15 M | 52.65 M | 67.61 M |
| Current Assets | 174.38 M | 152.02 M | 144.44 M | 170.14 M |
| Current Liabilities | 100.8 M | 63.61 M | 67.52 M | 117.06 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 4.84 M | 11.36 M | -43.17 M | -25.61 M |
| Investing CF | -6.17 M | -8.13 M | 8.62 M | 8.46 M |
| Financing CF | 0.23 M | 4.96 M | 10.67 M | 4.19 M |
| Free CF | 1.11 M | 8.52 M | -47.77 M | -27.61 M |
| Capex | -3.73 M | -2.84 M | -4.6 M | -2 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 14.35% | 15.29% | -3.51% | — |
| Earnings Growth % | 25.29% | 44.2% | 12.37% | — |
| Profit Margin % | -7.58% | -11.6% | -23.98% | -26.4% |
| Operating Margin % | -4.21% | -7.89% | -16.84% | -21.03% |
| Gross Margin % | 54.47% | 55.21% | 55.25% | 53.75% |
| EBITDA Margin % | -2.67% | -5.56% | -16.84% | -20.69% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.